Jeffrey M. Karp,Yuhan Lee,Ali Tavakkoli,Tarawatie E. Deelman
申请号：
US15763018
公开号：
US20200046754A1
申请日:
2016.09.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This disclosure relates to compositions including formulated sucralfate or other aluminum-crosslinked sulfated agents for delivery of agents to biological surfaces and/or the modulation of nutrient absorption through the intestinal lining as well as methods for the manufacture of and the use of these compositions for treating disorders including diabetes type II and clinical obesity that require a modulation of certain nutrients to the body.
